Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy.
Takashi FurutaHiroki YasudoSeigo OkadaYuji OhnishiAkiko Kawakami-MiyakeYasuo SuzukiShouichi OhgaShunji HasegawaPublished in: World journal of pediatrics : WJP (2022)
Keyphrases